Evidence map›Paper›PMID 25672759›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

miR-182 is largely dispensable for adaptive immunity: lack of correlation between expression and function.

Joseph N Pucella, Wei-Feng Yen, Myoungjoo V Kim, Joris van der Veeken, Chong T Luo, Nicholas D Socci, Yukiko Naito, Ming O Li, Naoharu Iwai, Jayanta Chaudhuri

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. miR-182 targeting reprograms tumor-associated macrophages and limits breast cancer progression.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Joseph N PucellaImmunology Program, Memorial Sloan Kettering Cancer Center, Gerstner Sloan Kettering Graduate School, New York, NY 10065;
Wei-Feng YenImmunology Program, Memorial Sloan Kettering Cancer Center, Gerstner Sloan Kettering Graduate School, New York, NY 10065; Immunology and Microbial Pathogenesis Program, Weill-Cornell Graduate School of Medical Sciences, New York, NY 10065;
Myoungjoo V KimImmunology Program, Memorial Sloan Kettering Cancer Center, Gerstner Sloan Kettering Graduate School, New York, NY 10065; Immunology and Microbial Pathogenesis Program, Weill-Cornell Graduate School of Medical Sciences, New York, NY 10065;
Joris van der VeekenImmunology Program, Memorial Sloan Kettering Cancer Center, Gerstner Sloan Kettering Graduate School, New York, NY 10065; Immunology and Microbial Pathogenesis Program, Weill-Cornell Graduate School of Medical Sciences, New York, NY 10065;
Chong T Luo
Nicholas D SocciBioinformatics Core, Memorial Sloan Kettering Cancer Center, New York, NY 10065; and.
Yukiko NaitoDepartment of Genomic Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka 565-8565, Japan.
Ming O LiImmunology Program, Memorial Sloan Kettering Cancer Center, Gerstner Sloan Kettering Graduate School, New York, NY 10065; Immunology and Microbial Pathogenesis Program, Weill-Cornell Graduate School of Medical Sciences, New York, NY 10065;
Naoharu IwaiDepartment of Genomic Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka 565-8565, Japan.
Jayanta ChaudhuriImmunology Program, Memorial Sloan Kettering Cancer Center, Gerstner Sloan Kettering Graduate School, New York, NY 10065; Immunology and Microbial Pathogenesis Program, Weill-Cornell Graduate School of Medical Sciences, New York, NY 10065; chaudhuj@mskcc.org.
Cornell University · USMemorial Sloan Kettering Cancer Center · USNational Cerebral and Cardiovascular Center · JP

Funding

Mechanistic Elucidation of Class Switch Recombination and Somatic HypermutationR01AI072194 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI CHAUDHURI, JAYANTA · 2009 to 2025
$6.9M
NIAID NIH HHS 1R01AI072194NIAID NIH HHS R01 AI072194
6 · The paper itself

Abstract

MicroRNA (miR)-mediated regulation of protein abundance is a pervasive mechanism of directing cellular processes. The well-studied and abundant miR-182 has previously been implicated in many aspects of T cell function, DNA repair, and cancer. In this study, we show that miR-182 is the most highly induced miR in B cells undergoing class-switch recombination. To elucidate the requirement of miR-182 in lymphocyte function, we extensively characterized mice with a targeted deletion of Mir182. We show that despite its dramatic induction, loss of miR-182 has minimal impact on B cell development, the ability of B cells to undergo class-switch recombination ex vivo and to undergo Ag-driven affinity maturation in vivo. Furthermore, in striking contrast to knockdown studies that demonstrated the requirement of miR-182 in T cell function, miR-182-deficient mice display no defect in T cell development and activation. Finally, we show that T cell-dependent immune response to experimental Listeria monocytogenes infection is intact in miR-182-deficient mice. We conclude that, contrary to previous studies, miR-182 does not play a significant role in all measured aspects of mouse adaptive immunity. This striking absence of a phenotype highlights the lack of correlation between expression pattern and functional requirement, underscores the limitations of using knockdown approaches to assess miR requirements, and suggests that miR networks may compensate for the chronic loss of specific miRs.

Indexed as

Adaptive ImmunityAnimalsB-LymphocytesFlow CytometryGene ExpressionHost-Pathogen InteractionsImmunoglobulin Class SwitchingListeria monocytogenesListeriosisLymphocyte ActivationMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutMicroRNAsReverse Transcriptase Polymerase Chain ReactionT-LymphocytesMicroRNAsMirn182 microRNA, mouse

Identifiers

PMID25672759
PMCPMC4355037
OpenAlexW1532732836

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.